2m 2m 2m 2m 2m 2m 2m
Ocular Therapeut (OCUL)
NASDAQ
$11.20+$0.12 (+1.04%)
Price as of Aug 21, 2026 7:52 PM EDT- $2.4BMarket Cap
- -9.92%1-Year Change
- BiotechnologyIndustry
Ocular Therapeut (OCUL)
$11.20+$0.12 (+1.04%)
OCUL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.08 | ||
Change | -$0.010 (-0.09%) | ||
Open | $11.10 | ||
High | $11.49 | ||
Low | $10.94 | ||
Previous Close | $11.09 | ||
Volume | 3,051,326 | ||
30-Day Average Volume | 2,747,398 | ||
1-Week Change | 10.36% | ||
1-Month Change | 24.08% | ||
1-Year Change | -9.92% | ||
3-Year Change | 183.38% | ||
5-Year Change | 10.69% | ||
Fundamentals | |||
Shares Outstanding | 219.6M | ||
Total Assets | $671.3M | ||
Market Cap | $2.4B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $13.5M | ||
Net Income | -$78.8M | ||
Free Cash Flow | -$70.6M | ||
EBIT | -$78.8M | ||
EBITDA | -$76.9M | ||
Net Working Capital | $595.3M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 142 | ||
P/B | 5 | ||
P/E | -32 | ||
PEG | -3 | ||
Price/Free Cash Flow | -34 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue